KYM Holdings Bhd (KLSE:KYM)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions MYR. Fiscal year is February - January.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 8, 2025	Jan 31, 2025	Jan 31, 2024	Jan 31, 2023	Jan 31, 2022	Jan 31, 2021
Market Capitalization	46	50	66	93	56	51
Market Cap Growth	-24.71%	-24.42%	-29.13%	64.73%	10.29%	36.00%
Enterprise Value	55	63	78	126	93	100
Last Close Price	0.30	0.33	0.43	0.61	0.38	0.34
PE Ratio	39.56	25.93	5.03	10.37	15.82	-
PS Ratio	0.56	0.58	0.65	0.77	0.68	0.73
PB Ratio	0.40	0.44	0.59	0.95	0.64	0.60
P/TBV Ratio	0.42	0.45	0.61	0.99	0.67	0.64
P/FCF Ratio	-	18.16	6.84	-	6.97	9.21
P/OCF Ratio	36.45	10.18	5.56	-	6.31	7.99
EV/Sales Ratio	0.67	0.74	0.77	1.04	1.12	1.42
EV/EBITDA Ratio	6.00	7.59	36.11	7.66	12.67	34.51
EV/EBIT Ratio	16.50	14.87	-	10.14	21.29	-
EV/FCF Ratio	-59.58	22.98	8.16	-	11.54	18.06
Debt / Equity Ratio	0.25	0.24	0.28	0.44	0.55	0.62
Debt / EBITDA Ratio	3.13	2.68	8.23	2.45	4.49	8.32
Debt / FCF Ratio	-	9.79	3.25	-	6.00	9.53
Asset Turnover	0.51	0.51	0.59	0.70	0.50	0.43
Inventory Turnover	3.59	2.95	3.29	3.46	4.33	3.78
Quick Ratio	1.59	1.30	1.49	0.55	0.73	0.63
Current Ratio	2.40	2.19	2.01	1.36	1.18	1.01
Return on Equity (ROE)	1.02%	1.69%	12.43%	9.58%	4.11%	-1.25%
Return on Assets (ROA)	1.28%	1.58%	-0.67%	4.49%	1.66%	-0.19%
Return on Capital (ROIC)	1.44%	1.86%	-0.81%	5.56%	1.99%	-0.23%
Return on Capital Employed (ROCE)	2.50%	3.20%	-	10.20%	3.80%	-
Earnings Yield	2.53%	3.86%	19.89%	9.64%	6.32%	-2.08%
FCF Yield	-2.01%	5.51%	14.62%	-2.95%	14.34%	10.86%
Buyback Yield / Dilution	0.51%	-0.05%	-1.02%	-0.73%	-	-

Updated Dec 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.